Caleb Jephcott
About Caleb Jephcott
Caleb Jephcott is a Senior Clinical Trial Monitor at Bristol Myers Squibb in Melbourne, Victoria, Australia, with extensive experience in clinical research and a background in emergency health.
Company
Caleb Jephcott is currently working at Bristol Myers Squibb as a Senior Clinical Trial Monitor. He is based in Melbourne, Victoria, Australia. Bristol Myers Squibb is known for its contribution to global healthcare through innovative drug development and clinical trials.
Title
Caleb Jephcott holds the title of Senior Clinical Trial Monitor at Bristol Myers Squibb. In this capacity, he oversees the planning, execution, and management of clinical trials to ensure compliance with regulatory standards and company protocols.
Education and Expertise
Caleb Jephcott completed his Bachelor of Emergency Health (Paramedics) at Victoria University, where he studied Emergency Medical Technology/Technician (EMT Paramedic) from 2009 to 2012. He previously attended Ivanhoe Grammar School from 1993 to 2006. His educational background in emergency health laid a robust foundation for his career in clinical research.
Background
Caleb Jephcott entered the field of clinical research shortly after completing his degree in emergency health. Starting as a Clinical Trial Study Coordinator at Monash University from 2013 to 2015, he transitioned to a Clinical Research Associate role at QuintilesIMS in 2015, later becoming a Senior Clinical Research Associate. His experience spans various well-known organizations, including DOCS, Syneos Health, and IQVIA.
Professional Experience
Caleb Jephcott has amassed over a decade of experience in clinical research. He has held multiple roles, including Senior Clinical Research Associate at DOCS, Syneos Health, and IQVIA. His career reflects significant adaptability and expertise in managing and monitoring clinical trials. Before his current role, his tenures included a brief period as Senior Clinical Research Associate II at Syneos Health in 2021 and a substantial period at QuintilesIMS from 2015 to 2019.